FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1479672098> ?p ?o ?g. }

• W1479672098 endingPage "415" @default.
• W1479672098 startingPage "406" @default.
• W1479672098 abstract "Study objective To compare the efficacy of two sequential therapy regimens of IV cefuroxime followed by oral cefuroxime axetil for the treatment of community-acquired pneumonia (CAP). Design Prospective, multicenter, randomized, open-label, parallel-group study. Setting Sixty-six centers in 11 countries (Belgium, Canada, Czech Republic, Germany, Hungary, Ireland, Israel, Poland, Portugal, South Africa, and the United Kingdom). Patients Six hundred thirty-six adults with CAP requiring hospitalization and initial IV antibiotic treatment. Interventions Cefuroxime, 1.5 g IV tid or bid for 48 to 72 h followed by oral cefuroxime axetil, 500 mg bid for 7 days. Measurements and results For clinically evaluable patients, the clinical response rates were equivalent for cefuroxime tid and bid groups posttreatment (cure/improvement, 79% and 84%, respectively) and at follow-up (maintained cure, 87% and 82%, respectively). All signs and symptoms of pneumonia showed improvement at the time of switch from IV to oral therapy. A total of 111 pathogens were isolated, the most common being Streptococcus pneumoniae (23%), Haemophilus influenzae (18%), and Enterobacteriaceae (15%). Bacteriologic clearance was obtained posttreatment in 47 of 49 and 36 of 42 of bacteriologically evaluable patients in the cefuroxime tid and bid groups, respectively. Both regimens were well tolerated with a low incidence of drug-related adverse events, the most common being GI. Conclusions Twice daily IV cefuroxime followed by oral cefuroxime axetil is a simple and effective sequential therapy regimen for the treatment of CAP. It offers potential cost savings and can replace the current tid regimen in this indication. To compare the efficacy of two sequential therapy regimens of IV cefuroxime followed by oral cefuroxime axetil for the treatment of community-acquired pneumonia (CAP). Prospective, multicenter, randomized, open-label, parallel-group study. Sixty-six centers in 11 countries (Belgium, Canada, Czech Republic, Germany, Hungary, Ireland, Israel, Poland, Portugal, South Africa, and the United Kingdom). Six hundred thirty-six adults with CAP requiring hospitalization and initial IV antibiotic treatment. Cefuroxime, 1.5 g IV tid or bid for 48 to 72 h followed by oral cefuroxime axetil, 500 mg bid for 7 days. For clinically evaluable patients, the clinical response rates were equivalent for cefuroxime tid and bid groups posttreatment (cure/improvement, 79% and 84%, respectively) and at follow-up (maintained cure, 87% and 82%, respectively). All signs and symptoms of pneumonia showed improvement at the time of switch from IV to oral therapy. A total of 111 pathogens were isolated, the most common being Streptococcus pneumoniae (23%), Haemophilus influenzae (18%), and Enterobacteriaceae (15%). Bacteriologic clearance was obtained posttreatment in 47 of 49 and 36 of 42 of bacteriologically evaluable patients in the cefuroxime tid and bid groups, respectively. Both regimens were well tolerated with a low incidence of drug-related adverse events, the most common being GI. Twice daily IV cefuroxime followed by oral cefuroxime axetil is a simple and effective sequential therapy regimen for the treatment of CAP. It offers potential cost savings and can replace the current tid regimen in this indication." @default.
• W1479672098 created "2016-06-24" @default.
• W1479672098 creator A5006503631 @default.
• W1479672098 creator A5017952264 @default.
• W1479672098 creator A5030720527 @default.
• W1479672098 creator A5039023366 @default.
• W1479672098 creator A5044050109 @default.
• W1479672098 creator A5074780704 @default.
• W1479672098 date "1997-08-01" @default.
• W1479672098 modified "2023-09-23" @default.
• W1479672098 title "Sequential Therapy With Cefuroxime Followed by Cefuroxime Axetil in Community-Acquired Pneumonia" @default.
• W1479672098 cites W182551149 @default.
• W1479672098 cites W1986024506 @default.
• W1479672098 cites W1991964388 @default.
• W1479672098 cites W1994459141 @default.
• W1479672098 cites W2010841382 @default.
• W1479672098 cites W2027162482 @default.
• W1479672098 cites W2027813229 @default.
• W1479672098 cites W2028987113 @default.
• W1479672098 cites W2030670372 @default.
• W1479672098 cites W2033278970 @default.
• W1479672098 cites W2050009848 @default.
• W1479672098 cites W2051039256 @default.
• W1479672098 cites W2062495428 @default.
• W1479672098 cites W2092561982 @default.
• W1479672098 cites W2143344021 @default.
• W1479672098 cites W2150000105 @default.
• W1479672098 cites W2152625385 @default.
• W1479672098 cites W2166809855 @default.
• W1479672098 cites W2166840599 @default.
• W1479672098 cites W2306746644 @default.
• W1479672098 cites W2359045121 @default.
• W1479672098 cites W2372543668 @default.
• W1479672098 cites W2382514453 @default.
• W1479672098 cites W2399227818 @default.
• W1479672098 cites W2412024993 @default.
• W1479672098 cites W2517346518 @default.
• W1479672098 cites W3143755808 @default.
• W1479672098 cites W2163733279 @default.
• W1479672098 doi "https://doi.org/10.1378/chest.112.2.406" @default.
• W1479672098 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9266876" @default.
• W1479672098 hasPublicationYear "1997" @default.
• W1479672098 type Work @default.
• W1479672098 sameAs 1479672098 @default.
• W1479672098 citedByCount "29" @default.
• W1479672098 countsByYear W14796720982013 @default.
• W1479672098 countsByYear W14796720982015 @default.
• W1479672098 countsByYear W14796720982018 @default.
• W1479672098 crossrefType "journal-article" @default.
• W1479672098 hasAuthorship W1479672098A5006503631 @default.
• W1479672098 hasAuthorship W1479672098A5017952264 @default.
• W1479672098 hasAuthorship W1479672098A5030720527 @default.
• W1479672098 hasAuthorship W1479672098A5039023366 @default.
• W1479672098 hasAuthorship W1479672098A5044050109 @default.
• W1479672098 hasAuthorship W1479672098A5074780704 @default.
• W1479672098 hasConcept C126322002 @default.
• W1479672098 hasConcept C141071460 @default.
• W1479672098 hasConcept C197934379 @default.
• W1479672098 hasConcept C2776102371 @default.
• W1479672098 hasConcept C2777514703 @default.
• W1479672098 hasConcept C2777914695 @default.
• W1479672098 hasConcept C2781413609 @default.
• W1479672098 hasConcept C501593827 @default.
• W1479672098 hasConcept C71924100 @default.
• W1479672098 hasConcept C86803240 @default.
• W1479672098 hasConcept C89423630 @default.
• W1479672098 hasConceptScore W1479672098C126322002 @default.
• W1479672098 hasConceptScore W1479672098C141071460 @default.
• W1479672098 hasConceptScore W1479672098C197934379 @default.
• W1479672098 hasConceptScore W1479672098C2776102371 @default.
• W1479672098 hasConceptScore W1479672098C2777514703 @default.
• W1479672098 hasConceptScore W1479672098C2777914695 @default.
• W1479672098 hasConceptScore W1479672098C2781413609 @default.
• W1479672098 hasConceptScore W1479672098C501593827 @default.
• W1479672098 hasConceptScore W1479672098C71924100 @default.
• W1479672098 hasConceptScore W1479672098C86803240 @default.
• W1479672098 hasConceptScore W1479672098C89423630 @default.
• W1479672098 hasIssue "2" @default.
• W1479672098 hasLocation W14796720981 @default.
• W1479672098 hasLocation W14796720982 @default.
• W1479672098 hasOpenAccess W1479672098 @default.
• W1479672098 hasPrimaryLocation W14796720981 @default.
• W1479672098 hasRelatedWork W142168780 @default.
• W1479672098 hasRelatedWork W2367465921 @default.
• W1479672098 hasRelatedWork W2374956397 @default.
• W1479672098 hasRelatedWork W2379887536 @default.
• W1479672098 hasRelatedWork W2381639959 @default.
• W1479672098 hasRelatedWork W2381717832 @default.
• W1479672098 hasRelatedWork W2391817365 @default.
• W1479672098 hasRelatedWork W3148793939 @default.
• W1479672098 hasRelatedWork W97342277 @default.
• W1479672098 hasRelatedWork W97493058 @default.
• W1479672098 hasVolume "112" @default.
• W1479672098 isParatext "false" @default.
• W1479672098 isRetracted "false" @default.
• W1479672098 magId "1479672098" @default.
• W1479672098 workType "article" @default.